Home > Quotes > CTHR > Guru Analysis > Motley Fool
CTHR

Motley Fool Guru Analysis for Charles & Colvard Ltd

$2.09
*  
0.03
1.46%
Get CTHR Alerts
*Delayed - data as of Jul. 22, 2014  -  Find a broker to begin trading CTHR now
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Assessments & Analysis Based on July 21, 2014 close price: $2.06

  for the Small Cap Growth Investor based on the criteria of Motley Fool. Return to CTHR Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 0%
Benjamin Graham 57%
Validea 0%
Motley Fool 8%
David Dreman 29%
Martin Zweig 15%
Kenneth Fisher 70%
James P. O'Shaughnessy 25%



Detailed Analysis

Guru Score: 8%


PROFIT MARGIN: [FAIL]

This methodology seeks companies with a minimum trailing 12 month after tax profit margin of 7%. The companies that pass this criterion have strong positions within their respective industries and offer greater shareholder returns. A true test of the quality of a company is that they can sustain this margin. CTHR's profit margin of -9.49% fails this test.


RELATIVE STRENGTH: [FAIL]

The investor must look at the relative strength of the company in question. Companies whose relative strength is 90 or above (that is, the company outperforms 90% or more of the market for the past year), are considered attractive. Companies whose price has been rising much quicker than the market tend to keep rising. CTHR, with a relative strength of 12, fails this test.


COMPARE SALES AND EPS GROWTH TO THE SAME PERIOD LAST YEAR: [FAIL]

Companies must demonstrate both revenue and net income growth of at least 25% as compared to the prior year. These growth rates give you the dynamic companies that you are looking for. These rates for CTHR (-350.00% for EPS, and -6.62% for Sales) are not good enough to pass.


INSIDER HOLDINGS: [FAIL]

CTHR's insiders should own at least 10% (they own 9.36%) of the company's outstanding shares. This does not satisfy the minimum requirement, and companies that do not pass this criteria are less attractive.


CASH FLOW FROM OPERATIONS: [FAIL]

A positive cash flow is typically used for internal expansion, acquisitions, dividend payments, etc. A company that generates rather than consumes cash is in much better shape to fund such activities on their own, rather than needing to borrow funds to do so. CTHR's free cash flow of $-0.07 per share fails this test.


PROFIT MARGIN CONSISTENCY: [FAIL]

The profit margin in the past must be consistently increasing. The profit margin of CTHR has been inconsistent in the past three years (Current year: -4.53%, Last year: 19.51%, Two years ago: 9.79%), which is unacceptable. This inconsistency will carryover directly to the company's bottom line, or earnings per share.


R&D AS A PERCENTAGE OF SALES: [NEUTRAL]

This criterion is not critically important for companies that are not high-tech or medical stocks because they are not as R&D dependant as companies within those sectors. Not much emphasis should be placed on this test in CTHR's case.


CASH AND CASH EQUIVALENTS: [FAIL]

Unfortunately, the data is unavailable for CTHR. Hence, an opinion cannot be rendered.


INVENTORY TO SALES: [PASS]

This methodology strongly believes that companies, especially small ones, should have tight control over inventory. It's a warning sign if a company's inventory relative to sales increases significantly when compared to the previous year. Up to a 30% increase is allowed, but no more. Inventory to Sales for CTHR was 37.59% last year, while for this year it is 45.88%. Although the inventory to sales is rising, it is below the max 30% that is allowed. The investor can still consider the stock if all other criteria appear very attractive.


ACCOUNT RECEIVABLE TO SALES: [PASS]

This methodology wants to make sure that a company's accounts receivable do not get significantly out of line with sales. It's a warning sign if a company's accounts receivable relative to sales increases significantly when compared to the previous year. Up to a 30% increase is allowed, but no more. Accounts Receivable to Sales for CTHR was 36.26% last year, while for this year it is 35.94%. Since the AR to sales is decreasing by -0.32% the stock passes this criterion.


LONG TERM DEBT/EQUITY RATIO: [PASS]

CTHR's trailing twelve-month Debt/Equity ratio (0.00%) is at a great level according to this methodology because the superior companies that you are looking for don't need to borrow money in order to grow.


"THE FOOL RATIO" (P/E TO GROWTH): [FAIL]

The "Fool Ratio" is an extremely important aspect of this analysis. Unfortunately, CTHR's "Fool Ratio" is not available due to a lack of one or more important figures. Hence, an opinion cannot be given at this time.

The following criteria for CTHR are less important which means you would place less emphasis on them when making your investment decision using this strategy:

AVERAGE SHARES OUTSTANDING: [PASS]

CTHR has not been significantly increasing the number of shares outstanding within recent years which is a good sign. CTHR currently has 20.0 million shares outstanding. This means the company is not taking any measures, with regards to the number of shares, that will dilute or devalue the stock.


SALES: [PASS]

Companies with sales less than $500 million should be chosen. It is among these small-cap stocks that investors can find "an uncut gem", ones that institutions won't be able to buy yet. CTHR's sales of $28.1 million based on trailing 12 month sales, are fine, making this company one such "prospective gem". CTHR passes the sales test.


DAILY DOLLAR VOLUME: [FAIL]

CTHR does not meet the Daily Dollar Volume (DDV of $0.0 million) test. It is required that this number be greater than $1 million and less than $25 million because these are the stocks that are liquid but remain relatively undiscovered by institutions. CTHR is too illiquid to be considered attractive at this time.


PRICE: [FAIL]

This is a very insignificant criterion for this methodology. But basically, low prices are chosen because "small numbers multiply more rapidly than large ones" and the potential for big returns expands. CTHR's price is not currently available. Therefore the current price cannot be evaluated at this time.


INCOME TAX PERCENTAGE: [FAIL]

CTHR's income tax paid expressed as a percentage of pretax income either this year (17.31%) or last year (-1227.27%) is below 20% which is cause for concern. Because the tax rate is below 20% this could mean that the earnings that were reported are unrealistically inflated due to the lower level of income tax paid. However, we have utilized a sophisticated formula so that the appropriate figures reflect a 'normal' tax rate (35%).

 
The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer